首页> 外文期刊>Artificial cells, nanomedicine, and biotechnology. >Junduqing extractive promotes the apoptosis of nasopharyngeal carcinoma cells through down-regulating Mcl-1 and Bcl-xL and up-regulating Caspase-3, Caspase-8 and Caspase-9
【24h】

Junduqing extractive promotes the apoptosis of nasopharyngeal carcinoma cells through down-regulating Mcl-1 and Bcl-xL and up-regulating Caspase-3, Caspase-8 and Caspase-9

机译:君都清提取物通过下调Mcl-1和Bcl-xL并上调Caspase-3,Caspase-8和Caspase-9促进鼻咽癌细胞凋亡

获取原文
       

摘要

This study aimed to investigate the effect of Junduqing extractive on proliferation, apoptosis, migration and invasion of nasopharyngeal carcinoma (NPC) cells and the involved mechanism. Junduqing extractive was prepared. CCK-8 assay found that IC50 of Junduqing extractive in HNE-1 cells was 2.99?mg/ml, so its concentration of 1.0, 2.0 and 3.0?mg/ml was selected to perform the following experiments. HNE-1, HNE-2 and HONE1 cells were then divided into four groups: (1) Control (no treatment); (2) 1.0?mg/ml (1.0?mg/ml Junduqing); (3) 2.0?mg/ml (2.0?mg/ml Junduqing) and (4) 3.0?mg/ml (3.0?mg/ml Junduqing). Cell viability, apoptosis, migration and invasion were examined by CCK-8 assay, annexin V-FITC/PI staining, scratch wound assay and transwell assay, respectively. Compared with the control group, the viability, migration rates and invasive capacity of HNE-1, HNE-2 and HONE1 cells with Junduqing treatments decreased significantly. Higher concentration of Junduqing extractive caused lower viability, smaller migration rates and weaker invasive capacity. Compared with the control group, the apoptosis of HNE-1, HNE-2 and HONE1 cells after treatment with 2.0 and 3.0?mg/ml of Junduqing extractive increased remarkably. Levels of Bcl-xL, Mcl-1, Caspase-3, Caspase-8 and Caspase-9 were examined by western blotting. Compared with the control group, the expression of Bcl-xL and Mcl-1 and the expression of Caspase-3, Caspase-8 and Caspase-9 in HNE-1, HNE-2 and HONE1 cells were significantly down-regulated and up-regulated, respectively, after treatment with Junduqing extractive. In conclusion, Junduqing extractive could inhibit the proliferation, migration and invasion, and promote the apoptosis of human NPC cells through down-regulating Mcl-1 and Bcl-xL and up-regulating Caspase-3, Caspase-8 and Caspase-9.
机译:本研究旨在探讨军毒清提取物对鼻咽癌(NPC)细胞增殖,凋亡,迁移和侵袭的影响及其机制。制备君都清提取物。 CCK-8检测发现,君度清提取物在HNE-1细胞中的IC50为2.99?mg / ml,因此选择其浓度为1.0、2.0和3.0?mg / ml进行以下实验。然后将HNE-1,HNE-2和HONE1细胞分为四组:(1)对照(未处理); (2)1.0?mg / ml(1.0?mg / ml君都清); (3)2.0?mg / ml(2.0?mg / ml君度清)和(4)3.0?mg / ml(3.0?mg / ml君度清)。通过CCK-8测定,膜联蛋白V-FITC / PI染色,划痕伤口测定和transwell测定来检测细胞活力,凋亡,迁移和侵袭。与对照组相比,均督清治疗后HNE-1,HNE-2和HONE1细胞的活力,迁移率和侵袭能力明显下降。较高浓度的君都清提取物导致较低的生存力,较小的迁移率和较弱的侵袭能力。与对照组相比,均度清提取液分别以2.0和3.0mg / ml处理后,HNE-1,HNE-2和HONE1细胞凋亡明显增加。通过蛋白质印迹检测Bcl-xL,Mcl-1,Caspase-3,Caspase-8和Caspase-9的水平。与对照组相比,HNE-1,HNE-2和HONE1细胞中Bcl-xL和Mcl-1的表达以及Caspase-3,Caspase-8和Caspase-9的表达均显着下调和上调。分别用君毒清提取物调理。总之,君度清提取物可通过下调Mcl-1和Bcl-xL以及上调Caspase-3,Caspase-8和Caspase-9抑制人NPC细胞的增殖,迁移和侵袭,并促进其凋亡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号